Showing 641 - 660 results of 11,927 for search '"Hepatocellular carcinoma"', query time: 0.18s Refine Results
  1. 641
  2. 642

    Pro-IGF2-induced hypoglycaemia associated with hepatocellular carcinoma by S A A van den Berg, C G Krol

    Published 2017-05-01
    “…As the patient was known to suffer from advanced-stage hepatocellular carcinoma, tumour-associated hypoglycaemia was suspected. …”
    Get full text
    Article
  3. 643
  4. 644

    Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients by Sheikh Omar Bittaye, Abubacarr Kambi, Momodou A. I. Tekanyi, Saydiba Tamba, Lamin Sanneh, Momodou Musa Sisawo, Abdoulie Jatta, Gibril Fatty, Adam Jeng, Momodou Salieu Jallow, Ousman Leigh, Ramou Njie

    Published 2023-09-01
    “…Abstract Background As a result of the lack of screening programs and the difficulty in making a proper diagnosis, the majority of hepatocellular carcinoma (HHC) patients present late in low-resource countries. …”
    Get full text
    Article
  5. 645

    Metastasis of Cancer Stem Cells Developed in the Microenvironment of Hepatocellular Carcinoma by Said M. Afify, Ghmkin Hassan, Amira Osman, Anna Sanchez Calle, Hend M Nawara, Maram Hussein Zahra, Samah EL-Ghlban, Hager Mansour, Md Jahangir Alam, Hagar A Abu Quora, Juan Du, Akimasa Seno, Yoshiaki Iwasaki, Masaharu Seno

    Published 2019-08-01
    “…In this study, CSCs converted from mouse iPSCs in the presence of CM from hepatocellular carcinoma (HCC) cell line Huh7 cells. These converted cells (miPS-Huh7cm cells) were established as the metastatic cells. …”
    Get full text
    Article
  6. 646

    Epigenetic regulation mechanism of EZH2 gene in hepatocellular carcinoma by ZHAO Yu-shan, JI Meng-die, DONG Yu-cheng, GUO Xin, SONG Bo-yuan, CHEN Yang

    Published 2022-06-01
    Subjects: “…hepatocellular carcinoma|enhancer of zeste homolog 2|epigenetic regulation…”
    Get full text
    Article
  7. 647
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652
  13. 653
  14. 654
  15. 655
  16. 656

    The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma by Tanner Wright, Yalong Wang, Mark T. Bedford

    Published 2021-01-01
    “…Both PRMT5 and SND1 are broadly expressed and their deregulation is reported to be associated with a range of disease phenotypes, including cancer. Hepatocellular carcinoma (HCC) is an example of a cancer type that often displays elevated PRMT5 and SND1 levels, and there is evidence that hyperactivation of this axis is oncogenic. …”
    Get full text
    Article
  17. 657
  18. 658

    Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis by Roberto Cannella, Adele Taibbi, Giorgia Porrello, Marco Dioguardi Burgio, Giuseppe Cabibbo, Tommaso Vincenzo Bartolotta

    Published 2020-11-01
    “…Hepatocellular carcinoma (HCC) is frequently associated with macrovascular invasion of the portal vein or hepatic veins in advanced stages. …”
    Get full text
    Article
  19. 659
  20. 660